Product Reports Resources Pricing Login Book a demo

OpenEvidence

Health Tech & Medtech · Miami, United States · Founded 2022

AI-driven clinical decision support enhancing healthcare outcomes at the point of care

Valuation $10–50B
Revenue $100–500M
Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for OpenEvidence and the history behind them.
Power Law Decacorn$10B+ valuation tier Thoroughbred$100M+ revenue
Knowledge graph
News David Sacks' Craft Ventures targets $1B fund after White House exit Aug 12, 2026 News OpenEvidence eyes $200M raise at $20B valuation, up from $12B Jul 20, 2026 News BaseTen raises $1.5B Series F at $13B valuation as AI inference demand surges Jun 23, 2026

Talent graph

OpenEvidence's talent

Book a demo to see the people
Employees mapped 127 incl. 9 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 16 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on OpenEvidence's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 12 investors entered at this stage
Bond
Craft Ventures
Nvidia
Thrive Capital
Sequoia
Conviction
Blackstone
GV
Kleiner Perkins
DST Global
Coatue Management
Greycroft Partners

Ownership

Who owns OpenEvidence

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Jan/2026). Percentages are indicative.

60% Founders
  • Sequoia Capital 8%

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where OpenEvidence has talent and traffic

Workforce by country
🇺🇸 United States · Miami HQ
Book a demo for the full country breakdown
Web traffic by country
11M monthly visits
across markets
🇺🇸 United States72.6%
🇨🇦 Canada6.5%
🇧🇷 Brazil3.9%
🇲🇽 Mexico1.7%
🇹🇼 Taiwan1.3%
Top 5 markets shown

Patent intelligence

$293k patent portfolio · 4 active families

Estimated portfolio value
$293k
<0.01% of valuation · 256.9× smaller than top peer Dental Monitoring ($75M)
4 active patent families
Where OpenEvidence innovates Computer programData libraryData miningData scienceDocumentation

Where OpenEvidence concentrates vs peers

Each axis is a top-10 topic across OpenEvidence and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

OpenEvidence's 1 investments and acquisitions.

Every disclosed deal where OpenEvidence appeared as a backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across OpenEvidence's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        OpenEvidence's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        1 of 1 deals

        Market sentiment

        What the market is saying about OpenEvidence

        An AI-synthesized read of the highest-engagement posts about OpenEvidence on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See OpenEvidence on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles